Also known as BrdU, Bromouracil deoxyriboside, 5-Bromouracil-2-deoxyriboside, 5-Bromouracil deoxyriboside, 5-Bromodesoxyuridine, 5-Bdu, 5-Bromodeoxyuridine, Broxuridine
~3 min read
Bromodeoxyuridine ('''5-bromo-2'-deoxyuridine, BrdU, BUdR, BrdUrd, broxuridine') is a synthetic nucleoside analogue with a chemical structure similar to thymidine. BrdU is commonly used to study cell proliferation in living tissues and has been studied as a radiosensitizer and diagnostic tool in people with cancer.
During the S phase of the cell cycle (when DNA replication occurs), BrdU can be incorporated in place of thymidine in newly synthesized DNA molecules of dividing cells. Cells that have recently performed DNA replication or DNA repair can be detected with antibodies specific for BrdU using techniques such as immunohistochemistry or immunofluorescence. BrdU-labelled cells in humans can be detected up to two years after BrdU infusion.
Bromodeoxyuridine ('''5-bromo-2'-deoxyuridine, BrdU, BUdR, BrdUrd, broxuridine''') is a synthetic nucleoside analogue with a chemical structure similar to thymidine. BrdU is commonly used to study cell proliferation in living tissues and has been studied as a radiosensitizer and diagnostic tool in people with cancer.
via Wikidata sitelinks · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).